Prevention of myocardial damage during coronary intervention

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 6, Issue 2, 2006, Pages 75-81

  Pasceri, Vincenzo ^a   Patti, Giuseppe ^b   Di Sciascio, Germano ^b  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Myocardial damage; Percutaneous coronary intervention; Statins; Stents

Indexed keywords

ADENOSINE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; NITRATE; PLACEBO; TICLOPIDINE; CARDIOVASCULAR AGENT; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

ADULT; ANGIOPLASTY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; DRUG MECHANISM; DRUG USE; ELECTROCARDIOGRAM; ENDOTHELIUM; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MICROEMBOLISM; MORTALITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; STABLE ANGINA PECTORIS; SYMPTOM; TRANSLUMINAL CORONARY ANGIOPLASTY; AGED; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; MIDDLE AGED; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; PYRROLES; TREATMENT OUTCOME;

EID: 33745882950     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152906777441858     Document Type: Article

References (37)

1. Califf, R.,M., Abdelmeguid, A.,E., Kuntz, R.E., Popma, J.J., Davidson, C.J., Cohen, E.A., Kleiman, N.S., Mahaffey, K.W., Topol, E.J., Pepine, C.J., Lipicky, R.J., Granger, C.B., Harrington, R.A., Tardiff, B.E., Crenshaw, B.S., Bauman, R.P., Zuckerman, B.D., Chaitman, B.R., Bittl, J.,A., Ohman, E.M. Myonecrosis after revascularization procedures. J. Am. Coll. Cordial., 1998, 31, 241-251.
2. Ioannidis, J.P.A., Karvouni, E., Katritis, D.G. Mortality risk conferred by small elevations of creatine-kinase MB isoenzyme after percutaneous intervention. J. Am. Coll. Cordiol., 2003, 42, 1406-1411.
3. Ricciardi, M.J., Wu, E., Davidson, C.J., Choi. K.M., Klocke, F.J., Bonow, R.O., Judd, R.M., Kim, R.J. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation, 2001, 103, 2780-2783.
4. Klein, L.W., Kramer, B.L., Howard, E., Lesch, M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J. Am. Coll. Cardiol., 1991, 17, 621-626.
5. Abdelmeguid, A.E., Whitlow, P.L., Sapp, S.K., Ellis, S.G., Yopol, E.J. Long-term oucome of transient, uncomplicated in-laboratory coornary artery closure. Circulation, 1995, 91, 2733-2741
6. Abdelmeguid, A.E., Topol, E.J., Whitlow, P.L., Sapp, S.K., Ellis, S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation, 1996, 94, 1528-1536.
7. Kugelmass, A.D., Cohen, D.J., Moscucci, M., Piana, R.N., Senerchia, C., Kuntz, R.E., Baim, D.S. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am. J. Cardiol., 1994, 74, 748-754.
8. Kini, A., Kini, S., Marmur, J.D., Bertea, T., Dangas, G., Cocke, T.P., Sharma, S.K. Incidence and mechanism of creatine kinase-MB enzyme elvation after coronary intervention with different devices. Catheter. Cardiovasc. Intervent., 1999, 48, 123-129.
9. Stone, G.W., Mehran, R., Dangas, G., Lansky, A.J., Kornowski, R., Leon, M.B. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation, 2001, 104, 642-647.
10. Akkerhuis, K.M., Alexander, J.H., Tardiff, B.E., Boersma, E., Harrington, R.A., Lincoff, A.M., Simoons, M.L. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation, 2002, 105, 554-556.
11. Brener, S.J., Ellis, S.G., Schneider, J., Topol, E.J. Frequency and long-term impact of myonecrosis after coronary stenting. Eur. Heart J, 2002, 23, 869-876.
12. Ellis, S.G., Chew, D., Chan, A., Whitlow, P.L., Schneider, J.P., Topol, E.J. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function and probable benefit of statin therapy. Circulation, 2002, 106, 1205-1210.
13. Brener, S.J., Lytle, B.W., Schneider, J.P., Ellis, S.G., Topol, E.J. Association between CK-MB elevation after percutaneous or surgical revascularization and three year mortality. J. Am. Coll. Cardiol., 2002, 40, 1961-1967.
14. Nallamothu, B.K., Bates, E.R. Periprocedural myocardial infarction and mortality. Causality versus association. J. Am. Coll. Cardiol., 2003, 42, 1412-1414.
15. Liu, M.W., Douglas, J.S., Lembo, N.J., King, S.B. Angiographic predictors of a rise in serum creatine kinase (distal embolization) after balloon angioplasty of saphenous vein coronary artery bypass graft. Am. J. Cardiol., 1993, 72, 514-517.
16. Iakovou, I., Mintz, G.S., Dangas, G., Abizaid, A., Mehran, R., Kobayashi, Y., Lansky, A.J., Aymong, E.D., Nikolsky, E., Stone, G.W., Moses, J.W., Leon, M.B. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J. Am. Coll. Cardiol., 2003, 42, 1900-1905.
17. Abdelmeguid, A.E., Topol, E.J. The myth of the myocardial "infarctlet" during percutaneous coronary revascularization procedures. Circulation, 1996, 94, 3369-3375.
18. Mehran, R., Dangas, G., Mintz, G.S., Lansky, A.J., Pichard, A.D., Satler, L.F., Kent, K.M., Stone, G.W., Leon, M.B. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravscular ultrasound study of 2256 patients. Circulation, 2000, 101, 604-610.
19. Kurz, D.J., Naegeli, B., Bertel, O. A double-blind randomized study of the effect of immediate intravenous nitroglycerin on the incidence of postprocedural chest pain and minor myocardial necrosis after elective coronary stenting. Am. Heart J., 2000, 139, 35-43.
20. Wang, F.W., Osman, A., Otero, J., Stouffer, G.A., Waxman, S., Afzal, A., Anzuini, A., Uretsky, B.F. Distal myocardial protection during percutaneous coronary intervention with an intracoronary blocker. Circulation, 2003, 107, 2914-2919.
21. Desmet, W., Dens, J., Coussement, P., Van de Werf, F. Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. Heart, 2002, 88, 293-295.
22. van der Heijden, D.J., Westendorp, I.C., Riezebos, R.K., Kiemeneij, F., Slagboom, T., van der Wieken, L.R., Laarman, G.J. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation. J. Am. Coll. Cardiol., 2004, 44, 20-24.
23. Patti, G., Colonna, G., Pasceri, V., Lassandro Pepe, L., Montanaro, A., Di Sciascio, G. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention. Results from the ARMYDA-2 study. Circulation, 2005, 111, 2099-2106
24. Blankenship, J.C., Tasissa, G., O'Shea, J.C., Iliadis, E.A., Bachour, F.A., Cohen, D.J., Lui, H.K., Mann, T. 3rd., Cohen, E., Tcheng, J.E. ESPRIT Investigators. Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. J. Am. Coll. Cardiol., 2001, 38, 653-658.
25. Islam, M.A., Blankenship, J.C., Balog, C., Iliadis, E.A., Lincoff, A.M., Tcheng, J.E., Califf, R.M., Topol, E.J. EPISTENT Investigators. Effect of abciximab on angiographic complications during percutaneous coronary stenting in the evaluation of platelet IIb/IIIa inhibition in stenting trial (EPISTENT). Am. J Cardiol., 2002, 90, 916-921.
26. Ellis, S.G., Brener, S.J., Lincoff, A.M., Moliterno, D.J., Whitlow, P.L., Schneider, J.P., Topol, E.J. β-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation, 2001, 104, 2685-2688.
27. Laskey, W.K. Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation, 1999, 99, 2085-2089.
28. Baim, D.S., Wahr, D., George, B., Leon, M.B., Greenberg, J., Cutlip, D.E., Kaya, U., Popma, J.J., Ho, K.K., Kuntz, R.E. Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomised trial of a distal protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation, 2002, 105, 1285-1290.
29. Chan. A.W., Bhatt, D.L., Chew, D.P., Quinn, M.J., Moliterno, D.J., Topol, E.J., Ellis, S.G. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation, 2002, 105, 691-696.
30. Herrmann, J., Lerman, A., Baumgart, D., Volbracht, L., Schulz, R., von Birgelen, C., Haude, M., Heusch, G., Erbel, R. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation, 2002, 106, 2180-2183.
31. Pasceri, V., Patti, G, Nusca, A., Pristipino, C., Richichi, G., Di Sciascio, G. ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention. Results from the ARMYDA study. Circulation, 2004, 110, 674-678.
32. Alpert, J.S., Thygesen, K., Antman, E., Bassand, J.P. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol., 2000, 36, 959-969.
33. Chan, A.W., Bhatt, D.L., Chew, D.P., Reginelli, J., Schneider, J.P., Topol, E.J., Ellis, S.G. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation, 2003, 107, 1750-1756.
34. Wassmann, S., Faul, A., Hennen, B., Scheller, B., Bohm, M., Nickenig, G. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Circ. Res., 2003, 93, e98-103.
35. Jones, S.P., Lefer, D.J. Cardioprotective action of acute HMG-CoA reductase inhibition in the setting of myocardial infarction. Acta Physiol Scand., 2001, 173, 139-143.
36. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994, 344, 1383-1389.
37. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W., McKillop, J.H., Packard, C.J. Prevention of coronary heart disease with pravastatin in men with hypercholes-terolemia: West of Scotland Coronary Prevention Study Group. N. Engl. J Med., 1995, 333, 1301-1307.